Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sporadic Inclusion Body Myositis”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Not applicableEnrolling By InvitationNCT06605612
What this trial is testing

Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders

Who this might be right for
Inclusion Body MyositisMyotonic DystrophyLimb-girdle and Facioscapulohumeral Muscular Dystrophies+9 more
LMU Klinikum 108
Not applicableActive Not RecruitingNCT07796776
What this trial is testing

The Aim of the Study is to Characterize Patients Exhibiting Muscular Atrophy and Weakness Who Require a Muscle Biopsy for Diagnosis (IBM vs Atypical MND), Through an Innovative Technique Which Enables the Evaluation of the Neuromuscular Junction Involvement in Each Condition

Who this might be right for
Inclusion Body Myositis (IBM)Motor Neuron Disease, Amyotrophic Lateral Sclerosis
IRCCS San Raffaele 30
Not applicableStudy completedNCT00898989
What this trial is testing

Muscle Strength and Inflammatory Response in Patients With Inclusion Body Myositis

Who this might be right for
Inclusion Body Myositis
Institut de Myologie, France 42
Not applicableStudy completedNCT05890833
What this trial is testing

The Risk of Falls Index for Patients With Neuromuscular Disorders

Who this might be right for
Inclusion Body MyositisMyotonic DystrophyFacioscapulohumeral Muscular Dystrophies+3 more
LMU Klinikum 30
Not applicableLooking for participantsNCT00017914
What this trial is testing

Adult and Juvenile Myositis

Who this might be right for
DermatomyositisPolymyositisInclusion Body Myositis
National Institute of Environmental Health Sciences (NIEHS) 1,200
Not applicableStudy completedNCT00001265
What this trial is testing

Study and Treatment of Inflammatory Muscle Diseases

Who this might be right for
DermatomyositisPolymyositis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 1,325
Large-scale testing (Phase 3)Active Not RecruitingNCT06450886
What this trial is testing

Long-term Extension Study of Ulviprubart (ABC008) in Subjects With Inclusion Body Myositis

Who this might be right for
Inclusion Body Myositis (IBM)
Abcuro, Inc. 270
Large-scale testing (Phase 3)Study completedNCT01925209
What this trial is testing

Efficacy and Safety of Bimagrumab/BYM338 at 52 Weeks on Physical Function, Muscle Strength, Mobility in sIBM Patients

Who this might be right for
Sporadic Inclusion Body Myositis
Novartis Pharmaceuticals 251
Not applicableStudy completedNCT00030212
What this trial is testing

Immune Abnormalities in Sporadic Inclusion Body Myositis

Who this might be right for
SporadicInclusion BodyMyositis
National Institute of Neurological Disorders and Stroke (NINDS) 80
Large-scale testing (Phase 3)Study completedNCT02481453
What this trial is testing

Rapamycine vs Placebo for the Treatment of Inclusion Body Myositis

Who this might be right for
Inclusion Body Myositis (IBM)
Institut National de la Santé Et de la Recherche Médicale, France 44
Testing effectiveness (Phase 2)Study completedNCT02753530
What this trial is testing

Study of Arimoclomol in Inclusion Body Myositis (IBM)

Who this might be right for
Inclusion Body Myositis
ZevraDenmark 152
Testing effectiveness (Phase 2)Looking for participantsNCT06536166
What this trial is testing

Ruxolitinib Treatment in Inclusion Body Myositis

Who this might be right for
Inclusion Body Myositis, Sporadic
Assistance Publique - Hôpitaux de Paris 80
Early research (Phase 1)UnknownNCT05032131
What this trial is testing

Cell Therapy for IBM by Muscle Injection of ADSVF

Who this might be right for
Inclusion Body Myositis
Assistance Publique - Hôpitaux de Paris 32
Large-scale testing (Phase 3)Study completedNCT02250443
What this trial is testing

Study of Long-term Safety, Efficacy Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis

Who this might be right for
Sporadic Inclusion Body Myositis (sIBM)
Novartis Pharmaceuticals 10
Large-scale testing (Phase 3)Ended earlyNCT04049097
What this trial is testing

Arimoclomol in Sporadic Inclusion Body Myositis - Open Label Extension Trial

Who this might be right for
Inclusion Body Myositis
ZevraDenmark 121
Not applicableUnknownNCT02735447
What this trial is testing

Pharmacoepidemiologic General Research Extension: PGRx-sIBM Study

Who this might be right for
Sporadic Inclusion Body Myositis
La-ser Europe Limited 190
Not applicableStudy completedNCT04975841
What this trial is testing

Inclusion Body Myositis Treatment With Celution Processed Adipose Derived Regenerative Cells

Who this might be right for
Inclusion Body Myositis
University of Kansas Medical Center 9
Not applicableStudy completedNCT04907162
What this trial is testing

Musculoskeletal Nociceptive Pain in Participants With Neuromuscular Disorders

Who this might be right for
Pompe Disease (Late-onset)Myotonic Dystrophy Type 1 (DM1)Myotonic Dystrophy Type 2+4 more
LMU Klinikum 82
Not applicableStudy completedNCT01734369
What this trial is testing

Environmental Risk Factors for Myositis in Military Personnel

Who this might be right for
DermatomyositisAdult PolymyositisInclusion Body Myositis+1 more
National Institute of Environmental Health Sciences (NIEHS) 37
Early research (Phase 1)Study completedNCT04659031
What this trial is testing

ABC008 in Ascending (Single Ascending Dose/Multiple Ascending Dose) Study in Patients With (IBM)

Who this might be right for
Inclusion Body Myositis
Abcuro, Inc. 19
Next Page